indocyanine green angiography
indocyanine green angiography is a medical device with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Retinal Blood Flow and Autoregulation
Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)
Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer Surgery
Intraoperative Assessment of Ureteral Perfusion in Women With Endometriosis
The Use of Indocyanine Green Angiography to Predict Expanded Flap Viability
Clinical Trials (6)
Retinal Blood Flow and Autoregulation
Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)
Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer Surgery
Intraoperative Assessment of Ureteral Perfusion in Women With Endometriosis
The Use of Indocyanine Green Angiography to Predict Expanded Flap Viability
Intraoperative Indocyanine Green Laser Angiography; Postoperative Outcomes for Autologous Tissue Flaps
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6